HYALURONIC ACID TEAR TROUGH

The initial consultation is decisive given this area's anatomical complexity and sensitivity. Dr Romano precisely assesses the lower infraorbital hollow, skin quality, deep tissues and eyelid-to-cheek relationship to confirm the indication. Detailed discussion defines realistic goals and explains expected benefits, limitations and specific precautions. A personalised quotation is provided at the end.

Treatment suits patients with hollowing in the lower infraorbital groove causing persistent shadow and tired-looking eyes. It is indicated for lost midfacial volume or support rather than skin colour or laxity. Injection is considered when skin quality is satisfactory. Rigorous assessment establishes the indication for natural results without heaviness or changed expression.

Injections correct the hollow responsible for permanent under-eye shadow. Restoring support reduces tiredness and improves eyelid-to-cheek continuity.
A main benefit is precision. Measured volumes preserve expression and facial balance without puffiness.
With an appropriate indication and rigorous technique, results are natural and stable, recovery straightforward and rapid.

Precautions before tear trough injections limit bruising and side effects.
In preceding days, avoid substances increasing bleeding risk, such as aspirin, anti-inflammatory medicines, certain anticoagulants or supplements. Alcohol and significant sun exposure should also be limited.
Skin must be healthy : avoid irritating or exfoliating care for one week before injection.

A session begins with careful observation at rest and in movement to identify actual hollow depth and impact on expression. This adapts treatment to individual anatomy and avoids overcorrection.
Slow, controlled injection restores a gentle eyelid-to-cheek transition. Dr Romano uses a cannula. The approach is deliberately conservative, depositing product gradually to respect thin tissues and fragile skin. The aim is not transformation, but a rested, harmonious appearance consistent with anatomy.

Product choice is essential because tissues are thin and particularly sensitive to volume changes. Low water affinity reduces swelling risk, while an even texture allows natural, invisible integration.
It must subtly correct the hollow without excess thickness or visible relief while remaining easily mouldable. Stability is also needed for lasting results without migration.
Rigorous selection is therefore indispensable for both safety and natural results.

Specific aftercare respects sensitivity and distinctive lymphatic drainage. Slight morning swelling from physiological fluid retention may occur in following days and resolves spontaneously within days. Avoid direct or prolonged pressure and major temperature changes, which may increase swelling.
Sleeping position influences recovery. Sleep on your back with the head slightly raised to limit swelling and promote its resolution.
Skincare must be gentle and non-occlusive to avoid disturbing integration.

The protocol relies on precise planning and thorough knowledge of under-eye anatomy. As excess volume is poorly tolerated, treatment is cautious, aiming to restore a natural eyelid-to-cheek transition rather than immediate, obvious correction.
Injection is deep with deliberately moderate quantities, accounting for regional lymphatic drainage and swelling risk.
Treatment is usually gradual, with possible later adjustment rather than complete filling in one session. This gives natural, lasting results with a high level of safety.

The expected result is clear but subtle improvement without changed expression. Reduced hollowing and shadow restore a smoother eyelid-to-cheek transition. Eyes look less tired and more rested while remaining natural. Effects are neither immediate nor dramatic : they develop as product integrates and any after-effects subside. The aim is measured, harmonious correction consistent with anatomy and age rather than complete erasure of time's signs.

The tear trough moves little, favouring durability. Product undergoes less mechanical stress than elsewhere and therefore absorbs more slowly.
Results generally last between 10 and 12 months, evolving gradually without sudden changes as the body naturally metabolises hyaluronic acid.
Even after product disappears, eyelid-to-cheek balance is often improved. Annual maintenance injections prolong results.

Recovery varies with sensitivity but is usually moderate and temporary. Slight swelling, sometimes greater on waking, may occur because of slow lymphatic drainage. Small bruises gradually fade. Tenderness may last a few days without significant pain. Results cannot be assessed immediately because full integration takes time, during which appearance gradually harmonises. Following aftercare supports straightforward recovery and natural, lasting results.

Patient accounts often highlight subtle but significant improvement. They describe less tired-looking eyes, reduced shadow and a gentler eyelid-to-cheek transition. Subtlety is frequently emphasised : others see a rested face without identifying transformation.
When an experienced doctor performs treatment, the experience is reassuring and consistent with initial expectations.